Inventor

BIRKMANN ALEXANDER

DE11 patents

⚠️ This page may combine multiple inventors who share the name “BIRKMANN ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AICURIS ANTI INFECTIVE CURES GMBH

7 patents

US10137117B2Nov 27, 2018

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

AICURIS ANTI INFECTIVE CURES GMBH6 citations81

US9889124B2Feb 13, 2018

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

AICURIS ANTI INFECTIVE CURES GMBH6 citations81

US11266636B2Mar 8, 2022

Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses

AICURIS ANTI INFECTIVE CURES GMBH2 citations68

US11021474B2Jun 1, 2021

N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof

AICURIS ANTI INFECTIVE CURES GMBH4 citations68

USRE49697EOct 17, 2023

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

AICURIS ANTI INFECTIVE CURES GMBH0 citations60

US12152022B2Nov 26, 2024

N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof

AICURIS ANTI INFECTIVE CURES GMBH0 citations58

US11213516B2Jan 4, 2022

Intravaginally applicable devices comprising antiviral compounds

AICURIS ANTI INFECTIVE CURES GMBH0 citations55

AICURIS GMBH & CO KG

3 patents

US9119786B2Sep 1, 2015

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

AICURIS GMBH & CO KG15 citations90

US9340535B2May 17, 2016

N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate

AICURIS GMBH & CO KG5 citations71

US12070451B2Aug 27, 2024

Sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof

AICURIS GMBH & CO KG1 citations57

AICURIS ANTI-INFECTIVE CURES GMBH

1 patent

US9592225B2Mar 14, 2017

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

AICURIS ANTI-INFECTIVE CURES GMBH8 citations81